Digital physical therapy company Hinge Health went public last week, raising $437 million and ending an IPO drought for ...

Novo Nordisk (NVO) announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and home delivery. The move follows competitor Eli Lilly (LLY ...

Novo Nordisk announced it is partnering with telehealth platforms to offer its blockbuster drug Wegovy. The move will help it capture a large number of consumers who had flocked to digital health ...

6 May 2025 – Novo Nordisk today announced that new data spanning the company’s industry-leading portfolio across metabolic and cardiovascular health will be presented at the upcoming 32 nd ...

Pharma giant Novo Nordisk is partnering ... statistics about the health risks of obesity and Big Pharma's high prices. The ad then promoted Hims & Hers' weight loss products, including compounded ...

MONDAY, April 21, 2025 (HealthDay News) -- The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging ... The seized counterfeit products display a combination ...

Him & Hers Health and Novo Nordisk are collaborating ... top-selling kinds of pharmaceuticals ever. The GLP-1 products, including Novo Nordisk's Wegovy and Ozempic, have shown efficacy in the ...

Health-care companies rose after strong earnings from one fast-growing company. Novo Nordisk shares rose after ... We sell different types of products and services to both investment professionals ...

The seized counterfeit products display ... Program and to Novo Nordisk (1-800-727-6500). More Information Originally published on healthday.com, part of the BLOX Digital Content Exchange.